Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125112822 | 12511282 | 2 | F | 20160401 | 20160808 | 20160629 | 20160818 | EXP | IE-HPRA-2016-027051 | IE-009507513-1606IRL011052 | MERCK | 38.83 | YR | F | Y | 71.00000 | KG | 20160818 | OT | IE | IE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125112822 | 12511282 | 1 | PS | PUREGON | FOLLITROPIN | 1 | Subcutaneous | 125 IU DAILY | 2125 | IU | U | 20582 | 125 | IU | POWDER FOR INJECTION | QD | |||
| 125112822 | 12511282 | 2 | SS | PREGNYL | CHORIOGONADOTROPIN ALFA | 1 | Subcutaneous | 5000 IU X 2 AMPS | U | 0 | POWDER FOR INJECTION | ||||||||
| 125112822 | 12511282 | 3 | SS | ORGALUTRAN | GANIRELIX ACETATE | 1 | Subcutaneous | 250 MICROGRAM, QD | 3750 | UG | U | 0 | 250 | UG | SOLUTION FOR INJECTION | QD | |||
| 125112822 | 12511282 | 4 | SS | YASMIN | DROSPIRENONEETHINYL ESTRADIOL | 1 | Oral | UNK | 0 | FILM-COATED TABLET | |||||||||
| 125112822 | 12511282 | 5 | SS | INOSITOL | INOSITOL | 1 | UNK, BID | U | 0 | BID | |||||||||
| 125112822 | 12511282 | 6 | SS | CRINONE | PROGESTERONE | 1 | NOCTE | U | 0 | GEL | QD | ||||||||
| 125112822 | 12511282 | 7 | C | ELTROXIN | LEVOTHYROXINE | 1 | MON-FRI | U | 0 | 200 | UG | TABLET | |||||||
| 125112822 | 12511282 | 8 | C | ELTROXIN | LEVOTHYROXINE | 1 | SAT + SUN | U | 0 | 100 | UG | TABLET | |||||||
| 125112822 | 12511282 | 9 | C | MEPERIDINE HYDROCHLORIDE. | MEPERIDINE HYDROCHLORIDE | 1 | U | 0 | 75 | MG | |||||||||
| 125112822 | 12511282 | 10 | C | DIAZEPAN | DIAZEPAM | 1 | Intravenous (not otherwise specified) | U | 0 | 5 | MG | ||||||||
| 125112822 | 12511282 | 11 | C | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | U | 0 | PRESSURISED INHALATION, SUSPENSION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125112822 | 12511282 | 1 | In vitro fertilisation |
| 125112822 | 12511282 | 2 | In vitro fertilisation |
| 125112822 | 12511282 | 3 | In vitro fertilisation |
| 125112822 | 12511282 | 5 | Polycystic ovaries |
| 125112822 | 12511282 | 11 | Asthma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125112822 | 12511282 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125112822 | 12511282 | Dyspnoea | |
| 125112822 | 12511282 | Pulmonary embolism |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125112822 | 12511282 | 1 | 20160310 | 20160326 | 0 | |
| 125112822 | 12511282 | 2 | 20160327 | 20160327 | 0 | |
| 125112822 | 12511282 | 3 | 20160313 | 20160327 | 0 | |
| 125112822 | 12511282 | 4 | 20160302 | 0 | ||
| 125112822 | 12511282 | 6 | 20160329 | 20160330 | 0 |